Compare TER & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TER | ALC |
|---|---|---|
| Founded | 1960 | 1945 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Electrical Products | Ophthalmic Goods |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.5B | 39.0B |
| IPO Year | N/A | N/A |
| Metric | TER | ALC |
|---|---|---|
| Price | $245.13 | $81.06 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 12 |
| Target Price | ★ $190.85 | $88.29 |
| AVG Volume (30 Days) | ★ 2.7M | 1.3M |
| Earning Date | 02-02-2026 | 02-24-2026 |
| Dividend Yield | 0.19% | ★ 0.27% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.75 | 2.10 |
| Revenue | $2,859,571,000.00 | ★ $10,185,000,000.00 |
| Revenue This Year | $10.18 | $5.76 |
| Revenue Next Year | $23.40 | $7.24 |
| P/E Ratio | $91.46 | ★ $37.80 |
| Revenue Growth | ★ 4.46 | 4.34 |
| 52 Week Low | $65.77 | $71.55 |
| 52 Week High | $253.61 | $99.20 |
| Indicator | TER | ALC |
|---|---|---|
| Relative Strength Index (RSI) | 66.97 | 54.82 |
| Support Level | $239.70 | $79.81 |
| Resistance Level | $238.00 | $81.42 |
| Average True Range (ATR) | 8.84 | 1.27 |
| MACD | 1.06 | 0.02 |
| Stochastic Oscillator | 72.58 | 73.80 |
Teradyne provides testing equipment, including automated test equipment for semiconductors, system testing for hard disk drives, circuit boards, and electronics systems and wireless testing for devices. The firm entered the industrial automation market in 2015, into which it sells collaborative and autonomous robots for factory applications. Teradyne serves numerous end markets and geographies directly and indirectly with its products, but its most significant exposure is to semiconductor testing. Teradyne serves vertically integrated, fabless, and foundry chipmakers with its equipment.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.